[2] Abenavoli, L., Capasso, R., Milic, N., & Capasso, F. (2010). Milk thistle in liver diseases: past, present, future. Phytotherapy research, 24(10), 1423-1432.
[3] Federico, A., Dallio, M., Loguercio, C., & Federico, A. (2017). Silymarin/silybin and chronic liver disease: A marriage of many years. Molecules, 22(2), 191.
[4] Rahmani, S., Asgary, S., Askari, G., Keshvari, M., Hatamipour, M., Feizi, A., ... & Sahebkar, A. (2016). Curcumin for treatment of non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. Phytotherapy research, 30(9), 1540-1548.
[5] Sahebkar, A., Simental-Mendía, L. E., Guerrero-Romero, F., & Reiner, Ž. (2015). Curcumin in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Phytotherapy research, 29(12), 1844-1854.
[6] Basu, A., Betts, N. M., Lyons, T. J., & Wu, M. (2017). Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. Journal of the American College of Nutrition, 36(7), 571-579.
[7] Chen, Y. K., & Lin, H. Z. (2015). Green tea and liver diseases. Liver international, 35(1), 30-39.